Company page
Agenus Inc.
Agenus Inc. is a public biotechnology company listed under the ticker AGEN, operating in the American market. The company has a market capitalization of approximately $267.6 million. Agenus focuses on developing innovative immuno-oncology therapies to improve cancer treatment options.
- Ticker
- AGEN:NASDAQ
- Asset type
- Stock
- Market cap
- $312.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD